Saturday, March 2nd, 2024

Alzheimer’s Disease: This medicine will cure Alzheimer’s! FDA approved, know how effective it is


highlights

Alzheimer’s has become a progressive disease.
Lecanimab becomes the first drug to slow down the effects of symptoms in Alzheimer’s patients
Alzheimer’s weakens the connections between brain cells

Alzheimer’s Disease: The US Food and Drug Administration (FDA) on Friday approved Lecanemab, a drug for Alzheimer’s disease. This disease affecting the brain has increased rapidly, for which there was no current treatment, but now lecanimab has been approved for use, although it was also used earlier, but then its trials were being done. According to the FDA’s statement, ‘It was tested in three levels, as a result of which the Administration, taking this important decision, has selected this drug as a possible treatment for Alzheimer’s disease.

What is Alzheimer’s?
According to Apollo Hospitals, ‘Alzheimer’s has become a progressive disease, which destroys the ability to perform memory and other important brain functions. It weakens the connections of the brain cells, due to which there is a problem in forgetting and concentrating. Its main symptoms are loss of memory and confusion. There is no proper treatment for this, but these symptoms can be improved with medicines and the right lifestyle.

Lecanimab, how is the treatment for Alzheimer’s disease?
Lecanimab is the first drug to slow down the effects of symptoms in Alzheimer’s patients. It is an antibody that targets the amyloid protein associated with this brain slowing disease. It strengthens our immune system, so that our immune can work effectively in preventing the formation of amyloid protein in the brain. The results of the research on this, ie Outcome, have been published in the New England Journal, which shows that the rate of progression of the disease can be reduced after treatment in patients receiving this drug.

Is Lecanimab medicine for everyone?
It is very important to take the advice of doctors for the treatment of Alzheimer’s disease. First discuss it openly with the doctors, only then take any medicine. According to Dr. Richard, director of the Alzheimer’s Prevention Clinic, if one is having side effects, if one is taking blood thinners, if one has any problems, they need to discuss it with the treating physician. is needed, and they need to seek medical attention immediately.”

Risk of heart attack is high in winter, know the warning signs, symptoms and prevention methods of heart attack in cold


There will be 13.8 million Alzheimer’s patients in America by 2060
According to the US Alzheimer’s Association, more than 6.5 million (6.5 million) people in the United States are living with Alzheimer’s disease, and this number is expected to increase to 13.8 million (13.8 million) by 2060. The Alzheimer’s Association welcomed the decision on Friday. “By slowing the progression of the disease in the early stages of Alzheimer’s, individuals will have more time to live independently,” said Joanne Pike, president and CEO of the association.

Tags: america, brainpower, disease, health, Lifestyle

Source Link

Whatsapp GroupJoin
Telegram channelJoin

Drink these 5 leaves mixed with stale mouth water in the morning, blood sugar will be under control throughout the day.

Diabetes It is a serious and incurable disease. Sugar disease is increasing rapidly in India and this is the reason why India is known as the capital of diabetes. According to the World Health...

My weight is very low and I am thin in appearance, how to gain weight?

It is necessary to be thin to stay fit, but being too thin is a sign of weakness. This problem is called being underweight. Such people often keep looking for the answer to the...

Sleep opens between 1-4 o’clock? Get the doctor checked immediately, study reveals – this problem is related to liver disease

Non alcoholic fatty liver disease (NAFLD) related to the presence of fatty cells in the liver, which affects people to varying degrees. Problems arise when these cells build up toxins in the body and...